JNJ

189.06

+1.45%↑

ABT

124.63

+0.17%↑

TMO

556.32

-0.37%↓

ISRG

529.81

-1.42%↓

DHR

214.87

+0.44%↑

JNJ

189.06

+1.45%↑

ABT

124.63

+0.17%↑

TMO

556.32

-0.37%↓

ISRG

529.81

-1.42%↓

DHR

214.87

+0.44%↑

JNJ

189.06

+1.45%↑

ABT

124.63

+0.17%↑

TMO

556.32

-0.37%↓

ISRG

529.81

-1.42%↓

DHR

214.87

+0.44%↑

JNJ

189.06

+1.45%↑

ABT

124.63

+0.17%↑

TMO

556.32

-0.37%↓

ISRG

529.81

-1.42%↓

DHR

214.87

+0.44%↑

JNJ

189.06

+1.45%↑

ABT

124.63

+0.17%↑

TMO

556.32

-0.37%↓

ISRG

529.81

-1.42%↓

DHR

214.87

+0.44%↑

Search

Kala Pharmaceuticals Inc

Fermé

0.72 -6.49

Résumé

Variation du prix de l'action

24h

Actuel

Min

0.72

Max

0.78

Chiffres clés

By Trading Economics

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+985.53% upside

Dividendes

By Dow Jones

Prochains Résultats

10 nov. 2025

Kala Pharmaceuticals Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

30 oct. 2025, 23:32 UTC

Actions en Tendance

Stocks to Watch: Amazon, Reddit, SPS Commerce

30 oct. 2025, 23:02 UTC

Résultats

AIA Group 3Q Value of New Business Grew

30 oct. 2025, 23:45 UTC

Market Talk

Gold Edges Higher Amid Prospects of Continued Central-Bank Demand -- Market Talk

30 oct. 2025, 23:00 UTC

Résultats

Amazon Posts 13% Revenue Jump, Strong Cloud Sales -- 3rd Update

30 oct. 2025, 22:59 UTC

Market Talk
Acquisitions, Fusions, Rachats

Global Equities Roundup: Market Talk

30 oct. 2025, 22:59 UTC

Market Talk
Acquisitions, Fusions, Rachats

Mineral Resources Bear Reckons Lithium Assets May Be Dressed Up For Sale -- Market Talk

30 oct. 2025, 22:56 UTC

Market Talk

Australia Shares Shaping to Pare Recent Losses -- Market Talk

30 oct. 2025, 22:35 UTC

Résultats

AIA Group 3Q Value of New Business Margin Was 58.2%, Up 5.7 Ppt on Year >1299.HK

30 oct. 2025, 22:35 UTC

Résultats

AIA Group 3Q Value of New Business $1.48B Vs. $1.16B>1299.HK

30 oct. 2025, 22:31 UTC

Résultats

Apple Expects Big December Quarter on iPhone Upgrades -- 2nd Update

30 oct. 2025, 22:29 UTC

Résultats

Amazon Posts 13% Revenue Jump, Strong Cloud Sales -- 2nd Update

30 oct. 2025, 22:27 UTC

Résultats

Minas Buenaventura 3Q EPS 66c >BVN

30 oct. 2025, 22:27 UTC

Résultats

Minas Buenaventura 3Q Rev $431M >BVN

30 oct. 2025, 22:27 UTC

Résultats

Minas Buenaventura 3Q Net $179M >BVN

30 oct. 2025, 22:16 UTC

Market Talk
Résultats

Amazon's Grocery Delivery Business Gains Ground -- Market Talk

30 oct. 2025, 22:14 UTC

Résultats

Review & Preview: A Tech Earnings Storm -- Barrons.com

30 oct. 2025, 22:00 UTC

Résultats
Acquisitions, Fusions, Rachats

The Day Pharma's Weight-Loss Gold Rush Intensified -- WSJ

30 oct. 2025, 21:39 UTC

Résultats

Amazon Stock Jumps on Earnings Beat. AWS Is Doing Fine. -- Barrons.com

30 oct. 2025, 21:26 UTC

Résultats

Amazon Stock Jumps on Earnings Beat. AWS Is Doing Fine. -- Barrons.com

30 oct. 2025, 21:14 UTC

Market Talk
Résultats

Apple Sees Record Quarterly Services Revenue -- Market Talk

30 oct. 2025, 21:09 UTC

Market Talk
Résultats

Global Equities Roundup: Market Talk

30 oct. 2025, 21:09 UTC

Market Talk
Résultats

Amazon Says One-Off Costs Ate Into Operating Income -- Market Talk

30 oct. 2025, 21:04 UTC

Résultats

Apple Expects Big December Quarter on iPhone Upgrades -- Update

30 oct. 2025, 21:03 UTC

Résultats

Eldorado Gold 3Q Gold Sales Were 116,529 Ounces at Avg Realized Gold Price Per Ounce Sold of $3,527 >ELD.T

30 oct. 2025, 21:03 UTC

Résultats

Eldorado Gold 3Q Gold Production Was 115,190 Ounces >ELD.T

30 oct. 2025, 21:00 UTC

Résultats

Eldorado Gold Skouries on Track for 1Q of 2026

30 oct. 2025, 21:00 UTC

Résultats

Eldorado Gold 3Q Adj EPS 41c >EGO

30 oct. 2025, 21:00 UTC

Résultats

Eldorado Gold 3Q Rev $434.7M >EGO

30 oct. 2025, 21:00 UTC

Résultats

Eldorado Gold 3Q Net $56M >EGO

30 oct. 2025, 21:00 UTC

Résultats

Eldorado Gold 3Q EPS 27c >EGO

Comparaison

Variation de prix

Kala Pharmaceuticals Inc prévision

Objectif de Prix

By TipRanks

985.53% hausse

Prévisions sur 12 Mois

Moyen 8.25 USD  985.53%

Haut 15 USD

Bas 1.5 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

3 ratings

1

Achat

2

Maintien

0

Vente

Éléments financiers

$

À Propos Kala Pharmaceuticals Inc

Kala Pharmaceuticals Inc
help-icon Live chat